2-Isopropyl-4-methylpyridin-3-amine CAS:1698293-93-4: A Key Pharmaceutical Intermediate for Cancer Therapies

As a dedicated manufacturer and supplier of high-quality pharmaceutical intermediates, we offer 2-Isopropyl-4-methylpyridin-3-amine, a crucial building block for innovative cancer treatments. This compound is essential for the synthesis of KRAS G12C inhibitors, targeting pancreatic, colorectal, and lung cancers. We provide reliable sourcing and competitive pricing for your research and development needs.

Get a Quote & Sample

Advantages of Sourcing from Our Company

Reliable Supply Chain

As a key manufacturer in China, we guarantee a stable and consistent supply of 2-Isopropyl-4-methylpyridin-3-amine, crucial for uninterrupted production runs. You can rely on us for your long-term supply needs.

Exceptional Purity Standards

We adhere to stringent quality control measures, ensuring our 2-Isopropyl-4-methylpyridin-3-amine meets high purity standards (97% min), vital for pharmaceutical applications. This commitment to quality helps prevent costly batch failures.

Expertise in Pharmaceutical Intermediates

Leveraging years of experience as a specialized supplier, we understand the critical requirements for pharmaceutical intermediates. We are committed to supporting your quest for innovative cancer treatments.

Key Applications and Product Specifications

KRAS G12C Inhibitor Synthesis

The primary application of 2-Isopropyl-4-methylpyridin-3-amine is as a critical reagent for synthesizing KRAS G12C inhibitors, offering new hope in the fight against various cancers.

Pharmaceutical R&D

This compound is essential for research and development in the pharmaceutical sector, enabling scientists to explore novel drug candidates and therapeutic pathways.

Organic Synthesis Reagent

As a versatile heterocyclic amine, it finds applications in various complex organic synthesis projects, providing a unique pyridine scaffold.

Manufacturing of Oncology Drugs

Our product serves as a key component in the manufacturing process of life-saving oncology drugs, demonstrating its importance in the pharmaceutical supply chain.